Cargando…

Characterization of cognitive impairment in adult polyglucosan body disease

Adult polyglucosan body disease (APBD) is a rare but probably underdiagnosed autosomal recessive neurodegenerative disorder due to pathogenic variants in GBE1. The phenotype is characterized by neurogenic bladder dysfunction, spastic paraplegia, and axonal neuropathy. Additionally, cognitive symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Zebhauser, Paul Theo, Cordts, Isabell, Hengel, Holger, Haslinger, Bernhard, Lingor, Paul, Akman, Hasan Orhan, Haack, Tobias B., Deschauer, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119871/
https://www.ncbi.nlm.nih.gov/pubmed/34999962
http://dx.doi.org/10.1007/s00415-022-10960-z
_version_ 1784710787328114688
author Zebhauser, Paul Theo
Cordts, Isabell
Hengel, Holger
Haslinger, Bernhard
Lingor, Paul
Akman, Hasan Orhan
Haack, Tobias B.
Deschauer, Marcus
author_facet Zebhauser, Paul Theo
Cordts, Isabell
Hengel, Holger
Haslinger, Bernhard
Lingor, Paul
Akman, Hasan Orhan
Haack, Tobias B.
Deschauer, Marcus
author_sort Zebhauser, Paul Theo
collection PubMed
description Adult polyglucosan body disease (APBD) is a rare but probably underdiagnosed autosomal recessive neurodegenerative disorder due to pathogenic variants in GBE1. The phenotype is characterized by neurogenic bladder dysfunction, spastic paraplegia, and axonal neuropathy. Additionally, cognitive symptoms and dementia have been reported in APBD but have not been studied systematically. Using exome sequencing, we identified two previously unreported bi-allelic missense GBE1 variants in a patient with severe memory impairment along with the typical non-cognitive symptoms. We were able to confirm a reduction of GBE1 activity in blood lymphocytes. To characterize the neuropsychological profile of patients suffering from APBD, we conducted a systematic review of cognitive impairment in this rare disease. Analysis of 24 cases and case series (in total 58 patients) showed that executive deficits and memory impairment are the most common cognitive symptoms in APBD.
format Online
Article
Text
id pubmed-9119871
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91198712022-05-21 Characterization of cognitive impairment in adult polyglucosan body disease Zebhauser, Paul Theo Cordts, Isabell Hengel, Holger Haslinger, Bernhard Lingor, Paul Akman, Hasan Orhan Haack, Tobias B. Deschauer, Marcus J Neurol Review Adult polyglucosan body disease (APBD) is a rare but probably underdiagnosed autosomal recessive neurodegenerative disorder due to pathogenic variants in GBE1. The phenotype is characterized by neurogenic bladder dysfunction, spastic paraplegia, and axonal neuropathy. Additionally, cognitive symptoms and dementia have been reported in APBD but have not been studied systematically. Using exome sequencing, we identified two previously unreported bi-allelic missense GBE1 variants in a patient with severe memory impairment along with the typical non-cognitive symptoms. We were able to confirm a reduction of GBE1 activity in blood lymphocytes. To characterize the neuropsychological profile of patients suffering from APBD, we conducted a systematic review of cognitive impairment in this rare disease. Analysis of 24 cases and case series (in total 58 patients) showed that executive deficits and memory impairment are the most common cognitive symptoms in APBD. Springer Berlin Heidelberg 2022-01-08 2022 /pmc/articles/PMC9119871/ /pubmed/34999962 http://dx.doi.org/10.1007/s00415-022-10960-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Zebhauser, Paul Theo
Cordts, Isabell
Hengel, Holger
Haslinger, Bernhard
Lingor, Paul
Akman, Hasan Orhan
Haack, Tobias B.
Deschauer, Marcus
Characterization of cognitive impairment in adult polyglucosan body disease
title Characterization of cognitive impairment in adult polyglucosan body disease
title_full Characterization of cognitive impairment in adult polyglucosan body disease
title_fullStr Characterization of cognitive impairment in adult polyglucosan body disease
title_full_unstemmed Characterization of cognitive impairment in adult polyglucosan body disease
title_short Characterization of cognitive impairment in adult polyglucosan body disease
title_sort characterization of cognitive impairment in adult polyglucosan body disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119871/
https://www.ncbi.nlm.nih.gov/pubmed/34999962
http://dx.doi.org/10.1007/s00415-022-10960-z
work_keys_str_mv AT zebhauserpaultheo characterizationofcognitiveimpairmentinadultpolyglucosanbodydisease
AT cordtsisabell characterizationofcognitiveimpairmentinadultpolyglucosanbodydisease
AT hengelholger characterizationofcognitiveimpairmentinadultpolyglucosanbodydisease
AT haslingerbernhard characterizationofcognitiveimpairmentinadultpolyglucosanbodydisease
AT lingorpaul characterizationofcognitiveimpairmentinadultpolyglucosanbodydisease
AT akmanhasanorhan characterizationofcognitiveimpairmentinadultpolyglucosanbodydisease
AT haacktobiasb characterizationofcognitiveimpairmentinadultpolyglucosanbodydisease
AT deschauermarcus characterizationofcognitiveimpairmentinadultpolyglucosanbodydisease